Followers | 839 |
Posts | 120700 |
Boards Moderated | 13 |
Alias Born | 09/05/2002 |
Wednesday, August 04, 2021 4:21:39 PM
https://finance.yahoo.com/news/evolus-reports-second-quarter-2021-200500498.html
2Q21 Jeuveau sales of $26.1M were up from $12.2M in 1Q21 and $20.6M in 4Q20. )Botulinum-toxin sales are seasonally stronger in Q2 and Q4 than in Q1 and Q3.)
Of the $261.M in 2Q21, $25.4M was in the US and $0.7M in Canada (via a partnership). EOLS has not issued any Jeuveau sales guidance.
EOLS expects an EU launch in “early 2022.”
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Recent EOLS News
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 11/06/2024 10:22:20 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/06/2024 09:37:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2024 09:15:12 PM
- Evolus Reports Third Quarter 2024 Results • Business Wire • 11/06/2024 09:05:00 PM
- Evolus to Participate in Stifel 2024 Healthcare Conference • Business Wire • 11/01/2024 12:00:00 PM
- Evolus Announces EU Approval of Estyme® Injectable Hyaluronic Acid Gels Under New Medical Device Regulation • Business Wire • 10/31/2024 06:02:00 PM
- Evolus Rewards™ Patient Loyalty Program Surpasses 1 Million Enrolled Consumers • Business Wire • 10/29/2024 12:00:00 PM
- Evolus to Report Third Quarter Financial Results on November 6, 2024 • Business Wire • 10/23/2024 12:00:00 PM
- Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 10/12/2024 02:53:00 AM
- Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 09/28/2024 01:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/07/2024 01:45:54 AM
- Evolus to Ring the Nasdaq Stock Market Closing Bell on Friday, September 13, 2024 • Business Wire • 09/06/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/04/2024 08:14:51 PM
- Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 08/09/2024 08:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/31/2024 09:00:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2024 08:12:11 PM
- Evolus Reports Second Quarter 2024 Results and Raises Full Year Revenue Guidance • Business Wire • 07/31/2024 08:05:00 PM
- Evolus to Hold Investor Day on September 12, 2024 • Business Wire • 07/31/2024 12:00:00 PM
- Evolus Expands Global Footprint with Introduction of Nuceiva® (botulinum toxin type A) in Australia • Business Wire • 07/30/2024 12:00:00 PM
- Evolus to Participate in the Canaccord Genuity 44th Annual Growth Conference • Business Wire • 07/25/2024 12:00:00 PM
- Evolus to Report Second Quarter Financial Results on July 31, 2024 • Business Wire • 07/17/2024 12:00:00 PM
- Evolus Announces Appointment of Albert G. White III to Board of Directors • Business Wire • 07/01/2024 12:00:00 PM
- Evolus Announces Submission of Premarket Approval Application to the U.S. Food and Drug Administration for First Two Evolysse™ Dermal Filler Products • Business Wire • 06/24/2024 12:00:00 PM
- Evolus Broadens International Presence with Launch of Nuceiva® (botulinum toxin type A) in Spain • Business Wire • 06/12/2024 12:00:00 PM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM